ANTIBODY TITRES TO A ROUGH-MUTANT STRAIN OF ESCHERICHIA COLI IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION

This publication has 18 references indexed in Scilit:

• Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia
  New England Journal of Medicine, 1986
• Ceftazidime as first-line therapy for fever in acute leukaemia
  Journal of Infection, 1985
• Prevention of fever and gram negative infection after open heart surgery by antiendotoxin.
  Thorax, 1985
• PREVENTION OF GRAM-NEGATIVE SHOCK AND DEATH IN SURGICAL PATIENTS BY ANTIBODY TO ENDOTOXIN CORE GLYCOLIPID
  The Lancet, 1985
• ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)
  The Lancet, 1984
• Graft-versus-host disease: pathophysiological and clinical aspects.
  Annual Review of Medicine, 1984
• TREATMENT WITH ANTI-GRAM-NEGATIVE ANTIBODIES
  The Lancet, 1983
• Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coli
  New England Journal of Medicine, 1982
• Endotoxaemia and renal failure in cirrhosis and obstructive jaundice.
  BMJ, 1976
• CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S
  Transplantation, 1974